Literature DB >> 19211755

Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Miguel Rodríguez Pulido1, Francisco Sobrino, Belén Borrego, Margarita Sáiz.   

Abstract

We constructed foot-and-mouth disease virus (FMDV) mutants bearing independent deletions of the two stem-loop structures predicted in the 3' noncoding region of viral RNA, SL1 and SL2, respectively. Deletion of SL2 was lethal for viral infectivity in cultured cells, while deletion of SL1 resulted in viruses with slower growth kinetics and downregulated replication associated with impaired negative-strand RNA synthesis. With the aim of exploring the potential of an RNA-based vaccine against foot-and-mouth disease using attenuated viral genomes, full-length chimeric O1K/C-S8 RNAs were first inoculated into pigs. Our results show that FMDV viral transcripts could generate infectious virus and induce disease in swine. In contrast, RNAs carrying the DeltaSL1 mutation on an FMDV O1K genome were innocuous for pigs but elicited a specific immune response including both humoral and cellular responses. A single inoculation with 500 microg of RNA was able to induce a neutralizing antibody response. This response could be further boosted by a second RNA injection. The presence of the DeltaSL1 mutation was confirmed in viruses isolated from serum samples of RNA-inoculated pigs or after transfection and five passages in cell culture. These findings suggest that deletion of SL1 might contribute to FMDV attenuation in swine and support the potential of RNA technology for the design of new FMDV vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211755      PMCID: PMC2663259          DOI: 10.1128/JVI.01836-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.

Authors:  P L Eblé; A Bouma; K Weerdmeester; J A Stegeman; A Dekker
Journal:  Vaccine       Date:  2006-10-09       Impact factor: 3.641

Review 2.  The structure-function relationship of the enterovirus 3'-UTR.

Authors:  Jan Zoll; Hans A Heus; Frank J M van Kuppeveld; Willem J G Melchers
Journal:  Virus Res       Date:  2008-08-30       Impact factor: 3.303

3.  Microparticle-mediated RNA immunization against bovine viral diarrhea virus.

Authors:  V B Vassilev; L H Gil; R O Donis
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

4.  Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication.

Authors:  M Sáiz; S Gómez; E Martínez-Salas; F Sobrino
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

5.  Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.

Authors:  V L Fowler; D J Paton; E Rieder; P V Barnett
Journal:  Vaccine       Date:  2008-02-22       Impact factor: 3.641

6.  Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Annamaria Jakab; Giorgia Clementi; Eva Borrás; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

Review 7.  Development of a live attenuated dengue virus vaccine using reverse genetics.

Authors:  Joseph E Blaney; Anna P Durbin; Brian R Murphy; Stephen S Whitehead
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

8.  Foot-and-mouth disease virus infection induces proteolytic cleavage of PTB, eIF3a,b, and PABP RNA-binding proteins.

Authors:  Miguel Rodríguez Pulido; Paula Serrano; Margarita Sáiz; Encarnación Martínez-Salas
Journal:  Virology       Date:  2007-04-18       Impact factor: 3.616

9.  Persistence of foot-and-mouth disease virus in cell culture revisited: implications for contingency in evolution.

Authors:  Mónica Herrera; Ana Grande-Pérez; Celia Perales; Esteban Domingo
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

10.  Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element.

Authors:  Mark J M van Ooij; Charlotta Polacek; Dirk H R F Glaudemans; Judith Kuijpers; Frank J M van Kuppeveld; Raul Andino; Vadim I Agol; Willem J G Melchers
Journal:  Nucleic Acids Res       Date:  2006-05-31       Impact factor: 16.971

View more
  13 in total

1.  Identification of RNA-protein interaction networks involved in the norovirus life cycle.

Authors:  Surender Vashist; Luis Urena; Yasmin Chaudhry; Ian Goodfellow
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

2.  RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice.

Authors:  Miguel Rodríguez-Pulido; Belén Borrego; Francisco Sobrino; Margarita Sáiz
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

3.  Functional analysis of RNA structures present at the 3' extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence.

Authors:  Dalan Bailey; Ioannis Karakasiliotis; Surender Vashist; Liliane Man Wah Chung; Jivan Rees; Jivan Reese; Nora McFadden; Alicia Benson; Felix Yarovinsky; Peter Simmonds; Ian Goodfellow
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

4.  Foot-and-mouth disease virus type O specific mutations determine RNA-dependent RNA polymerase fidelity and virus attenuation.

Authors:  Chen Li; Haiwei Wang; Tiangang Yuan; Andrew Woodman; Decheng Yang; Guohui Zhou; Craig E Cameron; Li Yu
Journal:  Virology       Date:  2018-02-20       Impact factor: 3.616

5.  In-cell SHAPE uncovers dynamic interactions between the untranslated regions of the foot-and-mouth disease virus RNA.

Authors:  Rosa Diaz-Toledano; Gloria Lozano; Encarnacion Martinez-Salas
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

Review 6.  Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.

Authors:  Raj Kumar Singh; Gaurav Kumar Sharma; Sonalika Mahajan; Kuldeep Dhama; Suresh H Basagoudanavar; Madhusudan Hosamani; B P Sreenivasa; Wanpen Chaicumpa; Vivek Kumar Gupta; Aniket Sanyal
Journal:  Vaccines (Basel)       Date:  2019-08-16

7.  Foot-and-mouth disease virus carrier status in Bos grunniens yaks.

Authors:  Huiyun Chang; Yanbin Ma; Tong Lin; Guozheng Cong; Junzheng Du; Jinling Ma
Journal:  Virol J       Date:  2013-03-11       Impact factor: 4.099

8.  Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development.

Authors:  Haixue Zheng; Jianhong Guo; Ye Jin; Fan Yang; Jijun He; Lv Lv; Kesan Zhang; Qiong Wu; Xiangtao Liu; Xuepeng Cai
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

9.  Both cis and trans Activities of Foot-and-Mouth Disease Virus 3D Polymerase Are Essential for Viral RNA Replication.

Authors:  Morgan R Herod; Cristina Ferrer-Orta; Eleni-Anna Loundras; Joseph C Ward; Nuria Verdaguer; David J Rowlands; Nicola J Stonehouse
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases.

Authors:  Stephen Berryman; Katy Moffat; Christian Harak; Volker Lohmann; Terry Jackson
Journal:  J Gen Virol       Date:  2016-04-19       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.